UPDATED Apr 23, 2024
High return on equity, past performance and sound balance sheet.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
PAYX | US$121.62 | 2.1% | 15.4% | US$43.8b | US$120.78 | PE26.4x | E6.3% | 2.9% | Commercial Services | ||
5904 | NT$474.00 | -1.1% | -17.9% | NT$49.1b | NT$614.40 | PE19.4x | E11.1% | 4.4% | Retail | ||
6920 | JP¥34,590.00 | -7.6% | 77.4% | JP¥3.1t | JP¥38,396.43 | PE56.9x | E22.4% | 0.6% | Semiconductors | ||
ELQ | zł3.03 | -13.9% | 148.4% | zł303.0m | zł4.80 | PE26.8x | S26.7% | n/a | Capital Goods | ||
BRKN | CHF99.20 | 0.6% | 4.4% | CHF1.1b | CHF101.00 | PE20.3x | E6.0% | 4.5% | Capital Goods | ||
EGAL | ج.م99.00 | -10.9% | 140.0% | ج.م40.8b | ج.م96.25 | PE7.5x | E3.8% | 6.6% | Materials | ||
543232 | ₹3,256.70 | 4.6% | 59.0% | ₹160.0b | ₹3,160.25 | PE49.3x | E15.0% | 1.2% | Commercial Services | ||
1450 | HK$1.44 | 0% | -27.3% | HK$2.0b | n/a | PE15.5x | E32.3% | 0% | Media | ||
NETBAY | ฿19.30 | -2.5% | -10.2% | ฿3.9b | ฿27.35 | PE21.4x | E11.8% | 4.7% | Software | ||
AVI | R85.46 | 0.7% | 24.6% | R28.3b | R93.20 | PE14x | E5.4% | 6.0% | Food, Beverage & Tobacco | ||
SLYG | лв68.00 | 1.2% | 202.2% | лв1.2b | лв61.68 | PE36.6x | E29.4% | 0.4% | Tech | ||
FOUR | UK£64.40 | 3.0% | 44.1% | UK£1.8b | UK£70.44 | PE21.2x | E7.1% | 2.7% | Media | ||
ULTA | US$419.27 | -1.2% | -23.4% | US$20.2b | US$561.02 | PE15.7x | E4.3% | n/a | Retail | ||
9633 | HK$44.30 | 3.6% | 5.9% | HK$498.2b | HK$49.07 | PE38.1x | E10.7% | 1.8% | Food, Beverage & Tobacco | ||
2345 | NT$412.00 | 1.0% | 40.9% | NT$226.0b | NT$617.50 | PE25.8x | E21.0% | 2.4% | Tech | ||
IDXX | US$493.80 | 3.3% | 2.6% | US$41.0b | US$585.81 | PE48.6x | E9.9% | n/a | Healthcare | ||
GWW | US$955.79 | 0.6% | 44.9% | US$47.0b | US$948.98 | PE25.7x | E6.7% | 0.8% | Capital Goods | ||
KNOS | UK£9.40 | -4.8% | -23.1% | UK£1.2b | UK£13.54 | PE28.2x | E18.0% | 2.6% | Software | ||
DUR | AU$1.06 | -10.2% | 8.7% | AU$264.1m | AU$1.62 | PE11.1x | E10.6% | 3.8% | Capital Goods | ||
500660 | ₹1,942.65 | 2.3% | 55.6% | ₹329.1b | ₹2,141.25 | PE62.2x | E21.1% | 1.6% | Pharmaceuticals & Biotech | ||
PABC | PK₨70.54 | 0.4% | 36.8% | PK₨24.7b | PK₨95.00 | PE5.7x | S15.3% | 9.9% | Materials | ||
6472 | NT$751.00 | -0.4% | 37.4% | NT$76.0b | NT$865.00 | PE25.1x | E22.9% | 1.6% | Pharmaceuticals & Biotech | ||
7033 | JP¥1,670.00 | 1.1% | -46.6% | JP¥27.0b | JP¥3,490.00 | PE16.7x | E28.8% | 1.1% | Commercial Services | ||
HLNE | US$113.49 | 2.9% | 57.8% | US$6.4b | US$118.60 | PE37.2x | E27.9% | 1.6% | Diversified Financials |